Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Respiratory Investigation
|
February 28, 2020
Deterioration of high-resolution computed tomography findings predicts disease progression after initial decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone
Hisao Higo, Nobuaki Miyahara, Akihiko Taniguchi, et al.
International Journal of Molecular Sciences
|
July 15, 2026
Contribution of Interleukin-22 Binding Protein to the Development of Allergen-Induced Airway Hyperresponsiveness
Ryota Sunami, Hisao Higo, Satoru Senoo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 27, 2016
[HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report]
Satoru Senoo, Tomohiko Mannami, Tomoki Tamura, et al.
Journal of Clinical Medicine
|
August 26, 2023
Switching to Dupilumab from Other Biologics without a Treatment Interval in Patients with Severe Asthma: A Multi-Center Retrospective Study
Hisao Higo, Hirohisa Ichikawa, Yukako Arakawa, et al.
Respiratory Research
|
February 8, 2022
Identification of targetable kinases in idiopathic pulmonary fibrosis
Hisao Higo, Kadoaki Ohashi, Shuta Tomida, et al.
Plos One
|
August 28, 2020
Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity ≤ 50%: A multi-center retrospective analysis
Satoru Senoo, Nobuaki Miyahara, Akihiko Taniguchi, et al.
Oncology Letters
|
November 16, 2020
Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction
Kazuya Nishii, Kadoaki Ohashi, Tomoki Tamura, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
November 10, 2020
The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis
Kota Araki, Rie Kinoshita, Nahoko Tomonobu, et al.
Journal of Clinical Medicine
|
November 27, 2024
The Clinical Significance of Interstitial Pneumonia with Autoimmune Features in Cryptogenic Organizing Pneumonia: A Prospective Multicenter Observational Study
Hisao Higo, Hirohisa Ichikawa, Yukako Arakawa, et al.
Respiratory Investigation
|
May 30, 2024
Predictors of exacerbation in Japanese patients with severe asthma: Analysis of the severe asthma research program (Okayama-SARP) cohort
Hisao Higo, Akihiko Taniguchi, Satoru Senoo, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Respiratory Investigation
|
February 28, 2020
Deterioration of high-resolution computed tomography findings predicts disease progression after initial decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone
Hisao Higo, Nobuaki Miyahara, Akihiko Taniguchi, et al.
International Journal of Molecular Sciences
|
July 15, 2026
Contribution of Interleukin-22 Binding Protein to the Development of Allergen-Induced Airway Hyperresponsiveness
Ryota Sunami, Hisao Higo, Satoru Senoo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 27, 2016
[HER2-Positive Advanced Gastric Cancer with Disseminated Intravascular Coagulation and Diffuse Bone Marrow Carcinomatosis Successfully Treated with S-1/Trastuzumab Chemotherapy--A Case Report]
Satoru Senoo, Tomohiko Mannami, Tomoki Tamura, et al.
Journal of Clinical Medicine
|
August 26, 2023
Switching to Dupilumab from Other Biologics without a Treatment Interval in Patients with Severe Asthma: A Multi-Center Retrospective Study
Hisao Higo, Hirohisa Ichikawa, Yukako Arakawa, et al.
Respiratory Research
|
February 8, 2022
Identification of targetable kinases in idiopathic pulmonary fibrosis
Hisao Higo, Kadoaki Ohashi, Shuta Tomida, et al.
Plos One
|
August 28, 2020
Nintedanib can be used safely and effectively for idiopathic pulmonary fibrosis with predicted forced vital capacity ≤ 50%: A multi-center retrospective analysis
Satoru Senoo, Nobuaki Miyahara, Akihiko Taniguchi, et al.
Oncology Letters
|
November 16, 2020
Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction
Kazuya Nishii, Kadoaki Ohashi, Tomoki Tamura, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
November 10, 2020
The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis
Kota Araki, Rie Kinoshita, Nahoko Tomonobu, et al.
Journal of Clinical Medicine
|
November 27, 2024
The Clinical Significance of Interstitial Pneumonia with Autoimmune Features in Cryptogenic Organizing Pneumonia: A Prospective Multicenter Observational Study
Hisao Higo, Hirohisa Ichikawa, Yukako Arakawa, et al.
Respiratory Investigation
|
May 30, 2024
Predictors of exacerbation in Japanese patients with severe asthma: Analysis of the severe asthma research program (Okayama-SARP) cohort
Hisao Higo, Akihiko Taniguchi, Satoru Senoo, et al.
Page
of 3